QSAR STUDY ON THE INHIBITION OF THE HUMAN CARBONIC ANHYDRASE CYTOSOLIC ISOZYME VII

J. Singh, M. Lakhwani, P.V. Khadikar, A.T. Balaban, B.W. Clare, C.T. Supuran

Research output: Contribution to journalArticlepeer-review

12 Citations (Web of Science)

Abstract

The inhibition of a newly cloned human carbonic anhydrase (CA, EC 4-2-1-1) isozyme VII (hCAII) by a series of 32 aromatic and heterocyclic sulfonamides, including some of the clinically used derivatives (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, and benzolamide, as well as the sulfamate antiepileptic drug topiramate), has been modeled using a set of distance-based topological indices and structural descriptors. The results have shown that the Balaban-type indices play a dominant role. Excellent results were obtained in multiparametric regressions. The results are discussed with a variety of statistical indicators.
Original languageEnglish
Pages (from-to)691-701
JournalRevue Roumaine de Chimie
Volume51
Issue number7-8
Publication statusPublished - 2006

Fingerprint

Dive into the research topics of 'QSAR STUDY ON THE INHIBITION OF THE HUMAN CARBONIC ANHYDRASE CYTOSOLIC ISOZYME VII'. Together they form a unique fingerprint.

Cite this